Intravenous (IV) hydration therapy refers to administering fluids directly into the veins to treat dehydration. It helps restore fluid and electrolyte balance in the body. Common products used in IV hydration therapy include IV bags, fluid pumps, tubing sets, catheters, and cannulas. IV therapy is significantly gaining popularity as an effective remedy for treating illnesses such as diarrhea, vomiting, hangovers, jet lag, and the common cold. Fluid administration through IV hydration therapy eliminates pain and provides faster relief compared to oral rehydration.
The global Europe IV Hydration Therapy Market is estimated to be valued at US$ 261.68 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics
Technological developments in IV therapy delivery systems like automated fluid pumps and easy-to-use ambulatory hydration kits are making IV treatment more convenient and accessible. Ambulatory or portable IV therapy allows for fluid administration outside hospitals, enabling patients to continue their daily routines while receiving hydration treatment. This growing popularity of ambulatory IV hydration is fueling demand.
Segment Analysis
The Europe IV hydration therapy market is dominated by the homecare setting sub-segment due to the rising preference for homecare services to receive IV therapy. Homecare IV hydration services provide flexibility, convenience and comfort to patients as they can receive treatment within the comfort of their homes without needing to visit hospitals or clinics. This is driving greater adoption of homecare IV therapy in Europe.
PEST Analysis
Political: Regulations supporting home-based healthcare and patient-centered care are driving growth.
Economic: Rising healthcare costs are prompting shift to lower-cost outpatient and homecare settings.
Social: Busy lifestyle and preference for convenience is increasing demand for home IV therapy services.
Technological: Advances in portable IV equipment and training of paramedics is supporting expansion of homecare services.
Key Takeaways
The Europe IV Hydration Therapy Market Size is expected to witness high growth over the forecast period. The region’s market is estimated to be valued at US$ 261.68 Mn in 2024. Germany dominates the regional market due to supportive reimbursement policies and greater focus on integrated healthcare.
Regional analysis
Germany accounts for the largest share of the European market due to favorable reimbursement coverage and initiatives to strengthen primary and community-based care. The UK also holds a significant market share supported by increasing utilization of IV therapy in outpatient settings for chronic diseases and cancer.
Key players
Key players operating in the Europe IV hydration therapy market are Thermo Fisher Scientific Inc, B. Braun Melsungen AG, Baxter, ICU Medical, Inc., Fresenius Kabi AG and JW Life Science. . Key players are focusing on expanding their homecare and outpatient service portfolios through partnerships.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it